The importance of patient-partnered research in addressing long COVID: Takeaways for biomedical research study design from the RECOVER Initiative’s Mechanistic Pathways taskforce
eLife · 2023
DOI: 10.7554/elife.86043 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2023. Verfasst von C Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population Health, NYU Grossman School of Medicine, New York, United States. Hauptthemen laut MEDLINE: COVID-19, Biomedical Research. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: NHLBI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
The NIH-funded RECOVER study is collecting clinical data on patients who experience a SARS-CoV-2 infection. As patient representatives of the RECOVER Initiative’s Mechanistic Pathways task force, we offer our perspectives on patient motivations for partnering with researchers to obtain results from mechanistic studies. We emphasize the challenges of balancing urgency with scientific rigor. We recognize the importance of such partnerships in addressing post-acute sequelae of SARS-CoV-2 infection (PASC), which includes ‘long COVID,’ through contrasting objective and subjective narratives. Long COVID’s prevalence served as a call to action for patients like us to become actively involved in efforts to understand our condition. Patient-centered and patient-partnered research informs the balance between urgency and robust mechanistic research. Results from collaborating on protocol design, diverse patient inclusion, and awareness of community concerns establish a new precedent in biomedical research study design. With a public health matter as pressing as the long-term complications that can emerge after SARS-CoV-2 infection, considerate and equitable stakeholder involvement is essential to guiding seminal research. Discussions in the RECOVER Mechanistic Pathways task force gave rise to this commentary as well as other review articles on the current scientific understanding of PASC mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Population Health, NYU Grossman School of Medicine, New York, United States.
- Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, United States.
- Department of Pediatrics, Division of Infectious Diseases, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, United States.
- Department of Biochemistry and Molecular Genetics, University of Illinois, College of Medicine, Chicago, United States.
- Department of Biochemistry & Molecular Biology, Howard University College of Medicine, Washington, United States.
- Department of Pandemic Equity, Vermont Center for Independent Living, Montpelier, United States.
ORCID-Profile: C Kim, Sindhu Mohandas, Jalees Rehman, Zaki A Sherif, K Coombs
Förderung
- NHLBI NIH HHS
- National Institutes of Health
Zitieren
APA
Kim, C., Chen, B., Mohandas, S., Rehman, J., Sherif, Z. A., Coombs, K., RECOVER Mechanistic Pathways Task Force, & RECOVER Initiative (2023). The importance of patient-partnered research in addressing long COVID: Takeaways for biomedical research study design from the RECOVER Initiative’s Mechanistic Pathways taskforce. eLife. https://doi.org/10.7554/elife.86043
Vancouver
Kim C, Chen B, Mohandas S, Rehman J, Sherif ZA, Coombs K, et al. The importance of patient-partnered research in addressing long COVID: Takeaways for biomedical research study design from the RECOVER Initiative’s Mechanistic Pathways taskforce. eLife. 2023. doi:10.7554/elife.86043
BibTeX
@article{Kim2023,
author = {Kim, C and Chen, Benjamin and Mohandas, Sindhu and Rehman, Jalees and Sherif, Zaki A and Coombs, K and RECOVER Mechanistic Pathways Task Force, RECOVER Mechanistic Pathways Task Force and RECOVER Initiative, RECOVER Initiative},
title = {The importance of patient-partnered research in addressing long COVID: Takeaways for biomedical research study design from the RECOVER Initiative’s Mechanistic Pathways taskforce},
journal = {eLife},
year = {2023},
doi = {10.7554/elife.86043}
}
EUVIMED